The organoid era: Bringing patient-relevant preclinical models to the lab
Drug development is a lengthy and costly process that takes at least 10 years on…
Drug development is a lengthy and costly process that takes at least 10 years on…
Challenging targets, such as membrane proteins or protein-protein interactions were considered undruggable in the past.…
Biotech firms partner with contract development and manufacturing organizations (CDMOs) to leverage their expertise in…
A primary concern in drug development is the binding of drugs to targets they are…
In recent years, artificial intelligence has been hailed as the next big thing in drug…
To speed up drug development and commercialization, most biotechs partner with contract development and manufacturing…
With the global Covid-19 outbreak in early 2020, pharma companies and biotechs have increasingly turned…
Mismanagement of R&D projects in biotech and pharma is more common than one might think…
Biospecimen quality is critical to the success of clinical research. Selecting the right supplier is…
Over the last decade, oncology drug development has been marred by the high attrition rates…
Bioburden detection is one of the quality control measures required to ensure drug safety –…
The rapid spread of Covid-19 around the world has left drug developers with limited time…